DNAPrint genomics, Inc.

Moffitt teams with genomics company to predict chemotherapy response

Published in Healthcare Mergers, Acquisitions and Ventures Week, May 1st, 2004

Timothy J. Yeatman, MD, associate center director for clinical investigations at the H. Lee Moffitt Cancer Center & Research Institute, and the Sarasota, Florida-based DNAPrint genomics, Inc., have formed a joint research program to develop and implement new clinical tests for predicting patient response to cancer chemotherapies.

In the new pharmacogenomics alliance, Moffitt physicians and scientists are teaming with DNAPrint to identify genetic variants that underlie poor patient response to various chemotherapies and also to implement new clinical tests at the Cancer Center.

These genetic variants will be combined with other biomarkers from...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2004-05-01)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

AMDL, Inc.
Cancer diagnostics company reports 101% increase in revenue
Abortion
Doctor testifies that banned type of abortion needs more study
Adoption Issues
Oklahoma health department to issue birth certificates to same-sex couples
Agendia BV
Pharmacogenomics firm closes series A financing round
Alliance for Lupus Research
Lupus group announces $6.7M in research grants
Alta Partners
Venture capital fund closes $475M in life sciences funds
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry